Hemalatha Vasireddy, MD
Board Certifications: Hematology, Internal Medicine and Medical Oncology
Specializations: Hematology
Languages: English and Telugu
Locations: Belleville, NJ, Montclair, NJ and Roselle, NJ
Call Belleville, NJ 973-751-8880
Call Montclair, NJ: 973-744-8000
Call Roselle, NJ: 908-259-8817
Dr. Vasireddy has been practicing medicine in New Jersey for more than 15 years. She completed comprehensive training in hematology and medical oncology with an emphasis on both inpatient and outpatient medical management. She also instructs internal medicine residents in hematology/oncology at the University of Medicine and Dentistry of New Jersey/Mountainside Hospital. She is a member of the Oncology Care Committee and co-chairman of the Transfusion Committee at Clara Maass Medical Center in Belleville.
Academic Appointments and Achievements
PROFESSIONAL MEMBERSHIPS
- American Society of Clinical Oncology
- American College of Physicians
- Oncology Society of New Jersey
- Cancer Committee at Mountainside Hospital in Montclair
Education
Medical Education
Bachelor of Medicine, Bachelor of Surgery, Guntur Medical College, University of Health Sciences, Guntar, India
RESIDENCY
New York Methodist Hospital affiliated with NY Hospital Cornell Medical Center
FELLOWSHIPS
Hematology/Oncology, New York Methodist Hospital affiliated with NY Hospital Cornell Medical Center
OBSERVERSHIP
Jersey Shore Medical Center
Call Belleville, NJ 973-751-8880
Call Montclair, NJ: 973-744-8000
Call Roselle, NJ: 908-259-8817
Locations
Patients may schedule appointments with Dr. Vasireddy at:
Ste. 200
Belleville NJ 07109
Phone:
Fax:
Hospital Affiliations
Staff physician at Clara Maass Medical Center in Belleville, Mountainside Hospital in Montclair, Cooperman Barnabas Medical Center in Livingston
We are here for you
For more information or to schedule an appointment, call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.